STAT January 17, 2025
Rachel Cohrs Zhang

15 drugs for conditions like cancer included in second round of price talks

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications.

The drugs are on a list of 15 whose prices will be negotiated this year in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech
Value-based payment models: Doctors describe the disconnect between theory and practice
Nurse anesthetists outnumber anesthesiologists billing Medicare
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
Fewer psychiatrists are billing Medicare: 5 things to know
Psychiatrists participating in Medicare Part B declines: Study

Share This Article